• Zum Hauptinhalt springen
  • Zum Footer springen

Munich Cance...

  • Talks
  • Calls
  • Devices
  • Jobs
  • Your Input
  • Contact
  1. MunichCancerTalks
  2. Talks
  3. M.Pellegrini / Death Becomes Them – Host Cells and Their Retroviruses

M.Pellegrini / Death Becomes Them – Host Cells and Their Retroviruses

TranslaTUM Seminar Series


Death Becomes Them – Host Cells and Their Retroviruses 

Prof. Dr. Marc Pellegrini 

Executive Director, Centenary Institute Professor, Faculty of Medicine and Health, The University of Sydney 

20 April 2026, 4:30 – 5:30 pm
Johannes B. Ortner Forum (Auditorium left part) 


About the speaker

Professor Marc Pellegrini is an infectious diseases physician, host-pathogen molecular biologist, and Executive Director at the Centenary Institute. An internationally renowned research scientist, Professor Pellegrini has over 20 years of experience working on chronic infections that include HIV, hepatitis B and tuberculosis.

Bridging the gap between basic science and translation into the clinic, Professor Pellegrini’s research focuses on the development of novel therapeutics and interventions for the management of infectious diseases that contribute significantly to global morbidity and mortality.

An expert on host-pathogen interactions, Professor Pellegrini is particularly interested in the targeting of host cell signalling pathways to promote clearance of infected cells to eradicate chronic infectious diseases. His work has resulted in 16 clinical trials, including that of interleukin-7 immunotherapy, which was approved for the treatment of a previously fatal disease (progressive multifocal leukoencephalopathy) caused by the JC virus. Professor Pellegrini and his team have been awarded a number of prizes including the Burnet Prize, the Bupa Health Researcher Award, the Frank Fenner Award, an NHMRC Excellence Award and two Eureka Prizes. He was elected as a Fellow of the Australian Academy of Health and Medical Sciences in 2018.


Host

Prof. Dr. Jürgen Ruland

Institute of Clinical Chemistry and Pathobiochemistry

TranslaTUM – Corporate Research Center for Translational Cancer Research

School of Medicine and Health

TranslaTUM – Corporate Research Center for Translational Cancer Research
81675 München

Key words: haematology, targeted therapies, immunotherapy

Datum

20.04.2026

Uhrzeit

16:30 - 17:30

Ort

Johannes B. Ortner Forum / left part TranslaTUM, Einsteinstraße 25, 81675 München

Veranstalter

Institute of Clinical Chemistry and Pathobiochemistry TUM Klinikum Rechts der Isar

Weitere Informationen

Flyer

iCal-Download

Save the date

Munich Cancer Talks on behalf of

DKTK / Deutsches Konsortium für Translationale Krebsforschung Partnerstandort München

CCC München / Comprehensive Cancer Center München

BZKF / Bayerisches Zentrum für Krebsforschung Standort München

TUM Klinikum / TUM Klinikum Rechts der Isar Technische Universität München

TUM / Technische Universität München

LMU Klinikum

LMU / Ludwig-Maximilians-Universität München

 

Anmeldung für Redakteure
Impressum | Datenschutz | Barrierefreiheitserklärung